Leukemia Lymphoma Society
Who We Are:
The Leukemia and Lymphoma Society is the leading non-profit organization for blood cancer information, resources, and patient support. The organization became established in 1949 by Rudolph and Antoinette de Villiers in honor of their son who was diagnosed with the disease. LLS mission is to find a cure for blood cancer and provide their patients with the best medical care and resources available. Since 1949, LLS has invested over 79.8 million dollars towards blood cancer research and funds over 300 research programs and 127 academic grants. These programs and grants have discovered breakthrough therapies and treatments that have showed successful results towards specific types of cancers. In order to continue research and treatment …show more content…
• Nearly 50 percent of new cancer therapies between 2000 and 2014 were for blood cancer patients.
• LLS has quadrupled the five-year survival rate since the 1960s.
• LLS convinced legislation to pass oral parity in 33 states.
• Newly discovered treatments: chemotherapy, immunotherapy and stem cell transplantation.
• The most common types of blood cancers are leukemia, lymphoma, and myeloma.
• LLS established several Research Grant Programs: Career Development Program, The Translational Research Program and The Screen to Lead.
• LLS eliminated Oregon’s two-year waiting period for stem cell transplants for uninsured blood cancer patients.
• LLS increased the child survival rate from three percent in 1964, to 90 percent today.
• LLS has 64 Chapters throughout the United States, and four in Canada.
• Approximately every three minutes one person in the United States is diagnosed with a blood cancer.
• Some of the most common symptoms of blood cancers are one or more enlarged lymph nodes, persistent flu-like symptoms such as fever, bone pain, excessive sweating, paleness, fatigue, or sudden weight …show more content…
LLS is dedicated to their patients and provides emotional support as well as financial help through their Co-Pay Assistance Program, which has provided over $200 million for blood cancer patients. Researchers have been able to understand the effects of transplantation treatment verse alternative treatment and any potential effects they could have on a patient’s survival rate. Researchers have also developed targeted therapies and immunotherapy drug kill specific cancer cells that attack the immune system. LLS has made powerful headway with the first successful use of genetically engineered T-Cells resulting in 89 percent of acute lymphoblastic leukemia patients experiencing a complete response rate. With more than one type of blood cancer, each person is a different situation and involves different approaches and treatments. With no way to prevent or pre-screen most blood cancers, improving or developing breakthrough therapies has created a more personalized treatment approach also called “targeted drugs.” LLS funds several programs and grants like the Translational Research Program (TRP) and the Therapy Acceleration Program (TAP) that get the most promising results into clinical trials and available for patients as quick as possible. The Quest for Cures is another LLS funded program that focuses on the unmet medical needs and
The Leukemia and Lymphoma Society is the leading non-profit organization for blood cancer information, resources, and patient support. The organization became established in 1949 by Rudolph and Antoinette de Villiers in honor of their son who was diagnosed with the disease. LLS mission is to find a cure for blood cancer and provide their patients with the best medical care and resources available. Since 1949, LLS has invested over 79.8 million dollars towards blood cancer research and funds over 300 research programs and 127 academic grants. These programs and grants have discovered breakthrough therapies and treatments that have showed successful results towards specific types of cancers. In order to continue research and treatment …show more content…
• Nearly 50 percent of new cancer therapies between 2000 and 2014 were for blood cancer patients.
• LLS has quadrupled the five-year survival rate since the 1960s.
• LLS convinced legislation to pass oral parity in 33 states.
• Newly discovered treatments: chemotherapy, immunotherapy and stem cell transplantation.
• The most common types of blood cancers are leukemia, lymphoma, and myeloma.
• LLS established several Research Grant Programs: Career Development Program, The Translational Research Program and The Screen to Lead.
• LLS eliminated Oregon’s two-year waiting period for stem cell transplants for uninsured blood cancer patients.
• LLS increased the child survival rate from three percent in 1964, to 90 percent today.
• LLS has 64 Chapters throughout the United States, and four in Canada.
• Approximately every three minutes one person in the United States is diagnosed with a blood cancer.
• Some of the most common symptoms of blood cancers are one or more enlarged lymph nodes, persistent flu-like symptoms such as fever, bone pain, excessive sweating, paleness, fatigue, or sudden weight …show more content…
LLS is dedicated to their patients and provides emotional support as well as financial help through their Co-Pay Assistance Program, which has provided over $200 million for blood cancer patients. Researchers have been able to understand the effects of transplantation treatment verse alternative treatment and any potential effects they could have on a patient’s survival rate. Researchers have also developed targeted therapies and immunotherapy drug kill specific cancer cells that attack the immune system. LLS has made powerful headway with the first successful use of genetically engineered T-Cells resulting in 89 percent of acute lymphoblastic leukemia patients experiencing a complete response rate. With more than one type of blood cancer, each person is a different situation and involves different approaches and treatments. With no way to prevent or pre-screen most blood cancers, improving or developing breakthrough therapies has created a more personalized treatment approach also called “targeted drugs.” LLS funds several programs and grants like the Translational Research Program (TRP) and the Therapy Acceleration Program (TAP) that get the most promising results into clinical trials and available for patients as quick as possible. The Quest for Cures is another LLS funded program that focuses on the unmet medical needs and